Highland Capital Management, LLC Novo Cure LTD Transaction History

Highland Capital Management, LLC

  • $1.73 Billion
  • Q3 2024

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2021

Jan 28, 2022
SELL
$75.08 - $121.99 $587,275 - $954,205
-7,822 Closed
0 $0
Q3 2021

Oct 25, 2021
SELL
$116.17 - $194.55 $80,389 - $134,628
-692 Reduced 8.13%
7,822 $909,000
Q2 2021

Jul 30, 2021
BUY
$130.4 - $225.58 $1.11 Million - $1.92 Million
8,514 New
8,514 $1.89 Million

Others Institutions Holding NVCR

# of Institutions
263
Shares Held
77M
Call Options Held
1.17M
Put Options Held
318K
View Full List

About NovoCure Ltd

NVCR Quotes by TradingView
  • Ticker NVCR
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Medical Instruments & Supplies
  • Shares Outstandng 104,950,000
  • Market Cap $3.25B
  • Description
  • NovoCure Limited, an oncology company, engages in the development, manufacture, and commercialization of tumor treating fields (TTFields) devices for the treatment of solid tumor cancers in the United States, Europe, the Middle East, Africa, Japan, and Greater China. Its TTFields devices include Optune for the treatment of glioblastoma; and Optu...
More about NVCR
Track This Portfolio

Track Highland Capital Management, LLC Portfolio

Follow Highland Capital Management, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Highland Capital Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Highland Capital Management, LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email